Declining infection rate provides challenge for Oxford coronavirus vaccine


Just days ago, scientists leading the University of Oxford's coronavirus vaccine development expressed optimism about their progress — more than 1,000 people in the United Kingdom have been inoculated already, and 10,000 more will be given the vaccine in May and June. But there's some cause for concern, The Telegraph reports.
Professor Adrian Hill, director of the University's Jenner Institute, said what was formerly an 80 percent chance of developing an effective vaccine by September — possibly in time for a potential second wave of infections — has dwindled to 50 percent. That's not because the team no longer believes in its work, which is reportedly still going well. Instead, the U.K.'s infection rate decline may make it tough to gauge the vaccine's efficacy. "It's a race against the virus disappearing, and against time," Hill said.
Hill only expects fewer than 50 of the 10,000 trial volunteers to catch the virus, which has faded since the U.K. and other countries implemented strict lockdowns, and if it turns out that fewer than 20 test positive, the study's results may be useless.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The vaccine showed promise when it was tested in six rhesus macaque monkeys earlier this year, but it will obviously need to show that it provides the same protection in humans before it can be distributed.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Jared and Ivanka's Albanian island
Under The Radar The deal to develop Sazan has been met with widespread opposition
-
Storm warning
Feature The U.S. is headed for an intense hurricane season. Will a shrunken FEMA and NOAA be able to respond?
-
U.S. v. Skrmetti: Did the trans rights movement overreach?
Feature The Supreme Court upholds a Tennessee law that bans transgender care for minors, dealing a blow to trans rights
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia